+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bronchopulmonary Dysplasia Drug"

From
From
Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 62 Pages
  • Global
From
From
Bronchial Dysplasia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bronchial Dysplasia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Bronchial Dysplasia - Pipeline Insight, 2020 - Product Thumbnail Image

Bronchial Dysplasia - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Bronchopulmonary Dysplasia - Pipeline Insight, 2020 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Bronchopulmonary Dysplasia - Pipeline Review, H2 2020 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 81 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Bronchopulmonary Dysplasia (BPD) is a chronic lung disease that affects premature infants. It is characterized by inflammation and scarring of the lungs, leading to difficulty breathing and other respiratory problems. Treatment for BPD typically involves the use of respiratory drugs, such as bronchodilators, corticosteroids, and antibiotics. These drugs help to reduce inflammation, improve lung function, and reduce the risk of infection. In addition, oxygen therapy and mechanical ventilation may be used to help manage the symptoms of BPD. The BPD drug market is a rapidly growing segment of the respiratory drug market. It is driven by the increasing prevalence of premature births, as well as the need for improved treatments for BPD. Companies in this market include GlaxoSmithKline, AstraZeneca, Merck, and Novartis, among others. These companies are focused on developing new drugs and therapies to improve the treatment of BPD. Show Less Read more